Events › B2B Event
B2B Event
2nd edition
2nd Annual BioCentury Grand Rounds - Europe is a conference focusing on the academia/industry interface, showcasing breakthrough science from early-stage biotechs, VCs, and biopharma leaders, with a focus on translating research into investable startups.
Exhibitor mix: The event focuses on presenting companies, academic innovators, VCs, and biopharma leaders in early-stage R&D.
Filter this event to your ICP.
Dozens of solution providers here. You probably care about 20–30. Tell us your ICP, we'll find them.
Request intelligence →Delivery within 24 hours · $1,250
⚠️ The exhibitor list for this event isn't publicly accessible yet. We'll work on it once you submit a request.
Organizer
BioCentury Inc. and EBD GroupPrivate · San Carlos, United States · Founded 1993
Co-organized event by BioCentury and EBD Group focused on partnering and investment for European biotech companies.
Why people attend
To discover early-stage biopharma innovations, network with investors and pharma BD leaders, and explore collaboration or licensing opportunities for drug development platforms.
Exhibitor categories
Sample matches
Filtered to a Series-B SaaS ICP. Your filter will be different.
Sample Match A
example.com
"Strong ICP match: Series B, EU expansion, VP Engineering and CTO attending."
Sample Match B
example.io
"Mid-stage SaaS with active GTM motion; product-led growth signals align with ICP."
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
Speakers
2 speakers at BioCentury Grand Rounds - Europe
president and CEO · Intergen Co. LP
"presentation of BIO's tax agenda to House Ways and Means Committee"
chairman of BIO's Emerging Company section
President · Biotechnology Industry Organization
More events in Netherlands
Frequently asked questions